Literature DB >> 15273506

Congenital disorders of glycosylation: a booming chapter of pediatrics.

Jaak Jaeken1, Hubert Carchon.   

Abstract

PURPOSE OF REVIEW: The detection and identification of new congenital disorders of glycosylation continues at a rapid pace. Sine June 2003, four new congenital disorders of glycosylation have been reported, making a total of 20 diseases (on average nearly 1 disease per year since the first report in 1980; 12 of these congenital disorders of glycosylation were identified in the past 6 years). RECENT
FINDINGS: Three of these newly discovered CDG are caused by defects in early steps of dolichol-linked oligosaccharide biosynthesis. Affected patients have a neurologic or a multisystem disease. The fourth new CDG is a completely new CDG type caused by a defect in an endoplasmic reticulum-Golgi shuttle protein carrying multiple glycosyltransferases and nucleotide-sugar transporters.
SUMMARY: Disorders of nearly all organs and systems have been reported and continue to be reported in congenital disorders of glycosylation. Therefore, it is strongly recommended that congenital disorders of glycosylation be considered in any child with an unexplained clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273506     DOI: 10.1097/01.mop.0000133636.56790.4a

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  14 in total

1.  [Dysmorphia and psychomotor retardation].

Authors:  T Struffert; E M Feldmann; O Schofer; W Reith
Journal:  Radiologe       Date:  2005-03       Impact factor: 0.635

Review 2.  Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx.

Authors:  P L Calvo; S Pagliardini; M Baldi; A Pucci; L Sturiale; D Garozzo; T Vinciguerra; C Barbera; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2008-12-09       Impact factor: 4.982

3.  Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.

Authors:  Dorothy A Thompson; Ruth J Lyons; Isabelle Russell-Eggitt; Alki Liasis; Herbert Jägle; Stephanie Grünewald
Journal:  J Inherit Metab Dis       Date:  2013-02-22       Impact factor: 4.982

4.  Expanding the Spectrum of PMM2-CDG Phenotype.

Authors:  Sandrine Vuillaumier-Barrot; Bertrand Isidor; Thierry Dupré; Christiane Le Bizec; Albert David; Nathalie Seta
Journal:  JIMD Rep       Date:  2011-12-25

5.  Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality.

Authors:  Christian Thiel; Torben Lübke; Gert Matthijs; Kurt von Figura; Christian Körner
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

6.  Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia.

Authors:  Carsten Bergmann; Manfred Fliegauf; Nadina Ortiz Brüchle; Valeska Frank; Heike Olbrich; Jan Kirschner; Bernhard Schermer; Ingolf Schmedding; Andreas Kispert; Bettina Kränzlin; Gudrun Nürnberg; Christian Becker; Tiemo Grimm; Gundula Girschick; Sally A Lynch; Peter Kelehan; Jan Senderek; Thomas J Neuhaus; Thomas Stallmach; Hanswalter Zentgraf; Peter Nürnberg; Norbert Gretz; Cecilia Lo; Soeren Lienkamp; Tobias Schäfer; Gerd Walz; Thomas Benzing; Klaus Zerres; Heymut Omran
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

Review 7.  The congenital disorders of glycosylation: a multifaceted group of syndromes.

Authors:  Erik A Eklund; Hudson H Freeze
Journal:  NeuroRx       Date:  2006-04

Review 8.  Structure and function of beta -1,4-galactosyltransferase.

Authors:  Pradman K Qasba; Boopathy Ramakrishnan; Elizabeth Boeggeman
Journal:  Curr Drug Targets       Date:  2008-04       Impact factor: 3.465

9.  Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain.

Authors:  Ana Lúcia Rebelo; Francesco Gubinelli; Pauline Roost; Caroline Jan; Emmanuel Brouillet; Nadja Van Camp; Richard R Drake; Radka Saldova; Abhay Pandit
Journal:  J Neuroinflammation       Date:  2021-05-16       Impact factor: 8.322

Review 10.  Molecular diversity and evolution of the Siglec family of cell-surface lectins.

Authors:  Takashi Angata
Journal:  Mol Divers       Date:  2006-11       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.